-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Crinetics Pharmaceuticals, Inc. quarterly and annual Revenues in USD history and change rate from 31 Dec 2019 to 30 Jun 2025.
- Crinetics Pharmaceuticals, Inc. Revenues for the quarter ending 30 Jun 2025 was $1,031,000, a 158% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. annual Revenues for 2024 was $1,039,000, a 74% decline from 2023.
- Crinetics Pharmaceuticals, Inc. annual Revenues for 2023 was $4,013,000, a 15% decline from 2022.
- Crinetics Pharmaceuticals, Inc. annual Revenues for 2022 was $4,737,000, a 339% increase from 2021.